LONG TERM COSTS AND OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS NOT RESPONDING TO CONVENTIONAL THERAPY TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: THE EXTENSION OF PSORIATIC ARTHRITIS COST EVALUATION (PACE) STUDY

被引：1
|
作者：
Cortesi, P. A. [1 ]
Olivieri, I [2 ,3 ,4 ,5 ]
de Portu, S. [6 ]
Salvarani, C. [7 ]
Cauli, A. [8 ]
Lubrano, E. [9 ]
Spadaro, A. [10 ]
Cantini, F. [11 ]
Cutro, M. [2 ,3 ,4 ,5 ]
Mathieu, A.
Matucci-Cerinic, M. [12 ]
Pappone, N. [13 ]
Punzi, L. [14 ]
Scarpa, R. [15 ]
Mantovani, L. G. [15 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] San Carlo Hosp Potenza, Potenza, Italy
[3] Madonna Grazie Hosp, Potenza, Italy
[4] San Carlo Hosp Potenza, Matera, Italy
[5] Madonna Grazie Hosp, Matera, Italy
[6] Medtron Int Sarl, Tolochenaz, Switzerland
[7] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[8] Univ Cagliari, Monserrato, Italy
[9] Univ Molise, Campobasso, Italy
[10] Univ Roma La Sapienza, I-00185 Rome, Italy
[11] Prato Hosp, Prato, Italy
[12] Univ Florence, Florence, Italy
[13] Fdn Maugeri IRCCS, Telese Terme, Italy
[14] Univ Padua, Padua, Italy
[15] Univ Naples Federico II, Naples, Italy
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1507
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [21] Gender Differences in Psoriatic Arthritis - Impact on Tumor Necrosis Factor Inhibitors Persistence and Response
    Vieira-Sousa, Elsa
    Eusebio, Monica
    Avila-Ribeiro, Pedro
    Khmelinskii, Nikita
    Cruz-Machado, Rita
    Rocha, Teresa Martins
    Bernardes, Miguel
    Santos-Faria, Daniela
    Silva, Joana Leite
    Santos, Helena
    Miguel, Claudia
    Carvalho, Pedro
    Costa, Tiago
    Teixeira, Lidia
    Meirinhos, Tiago
    Nero, Patricia
    Fonseca, Joao Eurico
    Santos, Maria Jose
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [22] Network metaanalysis and cost per responder of tumor necrosis factor, interleukin, and phosphodiesterase inhibitors in the treatment of psoriatic arthritis
    Strand, Vibeke
    Husni, M. Elaine
    Griffith, Jenny
    Betts, Keith
    Beppu, Marci
    Song, Yan
    Ganguli, Arijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB260 - AB260
  • [23] The Effects of Tumor Necrosis Factor Inhibitors in a Particular Association of Psoriatic Arthritis and Behcet Disease
    Musetescu, Anca Emanuela
    Florescu, Alesandra
    Bumbea, Ana-Maria
    Florescu, Lucian Mihai
    Ciurea, Paulina Lucia
    Bondari, Andrei
    Florescu, Dan Nicolae
    Bondari, Simona
    REVISTA DE CHIMIE, 2019, 70 (03): : 1067 - 1070
  • [24] Two case reports of Mycobacterium marinum infection with psoriatic arthritis treated by tumor necrosis factor-α inhibitors
    Furuichi, Yuki
    Ito, Yoshihiro
    Tanese, Keiji
    Mukai, Miho
    Uwamino, Yoshifumi
    Hasegawa, Naoki
    Amagai, Masayuki
    Umegaki-Arao, Noriko
    JOURNAL OF DERMATOLOGY, 2021, 48 (02): : E106 - E107
  • [25] The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2008, 10 (4) : 295 - 296
  • [26] A cost-efficacy analysis of subcutaneous anti-tumor necrosis factor therapy in the treatment of psoriatic arthritis
    Tandon, N.
    Kavanaugh, A.
    Han, C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB6 - AB6
  • [27] Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US
    Strand V.
    Husni E.
    Griffith J.
    Zhou Z.-Y.
    Signorovitch J.
    Ganguli A.
    Rheumatology and Therapy, 2016, 3 (2) : 305 - 322
  • [28] Minimal Disease Activity and Anti-Tumor Necrosis Factor Therapy in Psoriatic Arthritis
    Haddad, Amir
    Thavaneswaran, Arane
    Ruiz-Arruza, Ioana
    Pellett, Fawnda
    Chandran, Vinod
    Cook, Richard J.
    Gladman, Dafna D.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (06) : 842 - 847
  • [29] Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis
    Kavanaugh, Arthur
    Tutuncu, Zuhre
    Catalan-Sanchez, Teresa
    CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) : 347 - 353
  • [30] Antiangiogenic effects of anti-tumor necrosis factor a therapy with infliximab in psoriatic arthritis
    Cañete, JD
    Pablos, JL
    Sanmartí, R
    Mallofré, C
    Marsal, S
    Maymó, J
    Gratacós, J
    Mezquita, J
    Mezquita, C
    Cid, MC
    ARTHRITIS AND RHEUMATISM, 2004, 50 (05): : 1636 - 1641
12345